1.
Gottlieb AB, Strober B, Tha?i D, Gordon K, Kundu S, Kisa R, Wei L, Banerjee S, Merola J. BMS-986165, an Oral, Selective TYK2 Inhibitor, in the Treatment of Moderate to Severe Psoriasis as Assessed by the Static Physician’s Global Assessment (sPGA)/Body Surface Area (BSA) Composite Tool (sPGAxBSA), a Clinically Useful Alternative to PASI. J of Skin [Internet]. 2020Sep.2 [cited 2022Aug.12];4(5):s29. Available from: https://www.jofskin.org/index.php/skin/article/view/978